SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-065866
Filing Date
2020-05-26
Accepted
2020-05-26 16:15:39
Documents
15
Period of Report
2020-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020882d1_8k.htm   iXBRL 8-K 46229
2 EXHIBIT 2.1 tm2020882d1_ex2-1.htm EX-2.1 770184
3 EXHIBIT 10.1 tm2020882d1_ex10-1.htm EX-10.1 869042
7 GRAPHIC tm2020882d1_ex10-1img001.jpg GRAPHIC 326017
  Complete submission text file 0001104659-20-065866.txt   2653643

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200520.xsd EX-101.SCH 3177
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200520_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200520_pre.xml EX-101.PRE 22706
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2020882d1_8k_htm.xml XML 3591
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 20910658
SIC: 2834 Pharmaceutical Preparations